Neonatal 2'-Fucosyllactose Supplementation Modulates Exploratory Behavior and Hippocampal Synaptic Plasticity in Rats Through Gut Microbiota and Metabolic Remodeling. [PDF]
Yu M +7 more
europepmc +1 more source
Intestinal neutral ceramidase, microbial metabolites and epithelial fucosylation in MASH. [PDF]
Llorente C.
europepmc +1 more source
<i>Bifidobacterium longum</i> Subspecies <i>infantis</i> M63 Enhances the Colitis-Alleviating Effect of 2'-Fucosyllactose by Restoring Intestinal Barrier Function and Microbial Metabolism. [PDF]
Zhang H, Li X, Tan M, Bao Y, Jiang S.
europepmc +1 more source
2'-Fucosyllactose and its metabolites propionate/butyrate suppress inflammation through a shared TLR4/p38 MAPK-dependent pathway <i>in vitro</i> and <i>in vivo</i>. [PDF]
Na K +9 more
europepmc +1 more source
Supplementation with 2'-fucosyllactose, a prebiotic human milk oligosaccharide (HMO), in a magnesium-containing medical food reduces chemotherapy-induced mucositis in Wistar rats. [PDF]
Kharait S +3 more
europepmc +1 more source
2'-Fucosyllactose Attenuates <i>Fusobacterium nucleatum</i> Virulence and Modulates the Oral Microbiota. [PDF]
Wu X +15 more
europepmc +1 more source
Hypoallergenicity of a hydrolyzed rice protein-based formula containing 2-fucosyllactose and lacto-N-neotetraose in children with cow's milk allergy: protocol for a randomized controlled study. The RIGHT-HY study. [PDF]
Zemrani B +11 more
europepmc +1 more source
Host-Specific Metabolic Engineering for Microbial Production of Fucosyllactoses. [PDF]
Kim BM +5 more
europepmc +1 more source
Metabolic interactions and growth dynamics of <i>Bifidobacterium</i> strains in response to human milk oligosaccharides and lactose. [PDF]
Ratering S +6 more
europepmc +1 more source

